NCT02687113

Brief Summary

The purpose of this study is to determine whether fusion technique of pre-radiofrequency ablation (RFA) cross-sectional imaging (CT or MR) and real-time ultrasonography would improve feasibility of RFA in patients with liver tumor in comparison with ultrasonography guidance alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2013

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 22, 2016

Completed
Last Updated

February 22, 2016

Status Verified

February 1, 2016

Enrollment Period

1.8 years

First QC Date

February 11, 2016

Last Update Submit

February 19, 2016

Conditions

Keywords

ablationfusion

Outcome Measures

Primary Outcomes (1)

  • RFA feasibility rates on planning USG with/without fusion CT/MR and US

    comparison of rates of RFA feasibility on conventional planning USG and on fusion planning USG

    10 minutes after finishing planning USG

Secondary Outcomes (2)

  • Rate of tumor visibility on planning USG with/without fusion technique

    10 minutes after finishing planning USG

  • Number of patients with safety access route on planning USG with/without fusion technique

    10 minutes after finishing planning USG

Other Outcomes (1)

  • Anticipated number of overlapping of RFA electrodes on planning USG with/without fusion technique

    30 minutes after finishing planning USG

Study Arms (1)

CT/US fusion

OTHER

patients undergo routine conventional feasibility planning ultrasound, and clinical decision of RFA feasibility is made based on conventional planning ultrasound. Then additional planning ultrasound using CT/US fusion technique is immediately performed by the same operator, and clinical decision is made based on fusion imaging.

Device: CT/US fusion

Interventions

Fusion of pre-RFA cross-sectional imaging (CT or MRI) and real-time USG using registration function of USG device.

CT/US fusion

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • referred to Radiology in our institution for liver tumor RFA
  • available pre-RFA liver CT or liver MR imaging within 6 weeks

You may not qualify if:

  • any contraindication of liver RFA
  • any patients who received treatment between pre-RFA imaging and planned RFA
  • patients referred for palliative purpose.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, South Korea

Location

Related Publications (1)

  • Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017 Feb;66(2):347-354. doi: 10.1016/j.jhep.2016.09.003. Epub 2016 Sep 17.

MeSH Terms

Conditions

Liver Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesLiver Diseases

Study Officials

  • Jeong Min Lee, MD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 11, 2016

First Posted

February 22, 2016

Study Start

March 1, 2013

Primary Completion

January 1, 2015

Study Completion

March 1, 2015

Last Updated

February 22, 2016

Record last verified: 2016-02

Data Sharing

IPD Sharing
Will not share

Locations